Be Part of the 2018 Study: Participate in Compliance Maturity in Scandinavian Life Science
Get the 2017 report: Compliance Maturity in the Danish Life Science Industry 2017
Ask Life Science executives how they feel about regulatory compliance, and they’ll often say it is an obstacle to achieving their overall company goals of growth, digitalization, patient centricity, beyond-the-pill services, and more. Talk to specialists and practitioners, and they’ll tell you that compliance is overly complicated and requirements are sometimes unclear.
The Life Science industry is asking serious questions about regulatory compliance:
- Are we over-spending on time and resources, actually hampering efficiency and our bottom line?
- Are we underspending and running the risk of compliance getting out-of-control?
We’re a consultancy dedicated to continuously improving regulatory compliance. Helping Life Science companies answer these questions led us to develop an innovative methodology to measure compliance.
Benchmarking the industry
In 2017, we conducted a large benchmarking study to provide a snapshot of where Danish Pharma, Biotech and Medical Device companies lie on the compliance maturity scale. The study’s results provide a valuable resource for Life Science professionals, shedding new light on important industry challenges and trends. Where does your company fall on this scale? Is compliance maturity optimal? The goal of the study was to provide insight and inspiration for you to make that assessment, and ultimately use the information to turn compliance obstacles into real opportunities that support your overall business goals. You can read the report here.
In 2018, we are taking the experience we gained from our previous study, and expanding our scope to all of Scandinavia. Participants will each receive an individual report for their company in order to benchmark their position against the rest of the industry. Click here to participate.
A note about confidentiality
All responses are treated as confidential information, and no results that identify a specific company or individual respondent will be made public. Results will only be shown as averages based on all participating companies, and no reference – in numbers or text – will reference individual companies or individuals. Individual company reports (sent only to the participating company itself) will show the company’s own results and how they compare to the industry average. This report will only be made available to the individual company.